Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Weighing Shortage Risk, FDA Clears Releasing Metabolic Formulas Made At Abbott’s Closed Plant

Apr 30 2022

• By Malcolm Spicer

• Source: Alamy

Related Content

Abbott Recalls Infant Formula Made At Facility FDA Is Investigating For Bacterial Contamination

Feb 18 2022

Abbott’s Earnings Guidance Unchanged With Questions On Formula Recall Unanswered

Mar 10 2022

Recall Sours Abbott’s Infant Formula Results; COVID-19 Test Sales Expected To Cool

Apr 20 2022

Requiring Infant Formula, Medical Food Shortage Updates Included In US FDA Budget Request

May 30 2021

Additional Topics

International United States US States FDA Recalls Pediatrics Dietary Supplements Advertising, Marketing & Sales Companies Commercial Consumer Distribution Ingredients Manufacturing Policy Regulation Safety

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window